Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TaiGen Biopharmaceuticals Holdings Limited (4157) Financial Statements

TaiGen Biopharmaceuticals Holdings Limited Financial Overview

TaiGen Biopharmaceuticals Holdings Limited's market cap is currently NT$5.78B. The company's EPS TTM is NT$0.22; its P/E ratio is 37.38; TaiGen Biopharmaceuticals Holdings Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 259.47MNT$ 150.65MNT$ 123.13MNT$ 36.23MNT$ 1.29B
Gross ProfitNT$ 223.83MNT$ 134.52MNT$ 111.69MNT$ 32.49MNT$ 1.28B
Operating IncomeNT$ 69.39MNT$ -122.10MNT$ -174.70MNT$ -217.15MNT$ 876.24M
EBITDANT$ 86.87MNT$ -6.63MNT$ 172.23MNT$ -200.37MNT$ 928.34M
Net IncomeNT$ 45.18MNT$ -38.58MNT$ 136.73MNT$ -237.16MNT$ 775.62M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.03BNT$ 1.02BNT$ 1.04BNT$ 899.50MNT$ 924.39M
Total AssetsNT$ 1.17BNT$ 1.17BNT$ 1.23BNT$ 1.05BNT$ 1.39B
Total DebtNT$ 49.22MNT$ 58.71MNT$ 74.69MNT$ 38.47MNT$ 53.46M
Net DebtNT$ -95.87MNT$ -15.43MNT$ -299.97MNT$ -204.64MNT$ -311.47M
Total LiabilitiesNT$ 92.38MNT$ 91.96MNT$ 110.94MNT$ 76.98MNT$ 139.11M
Stockholders' EquityNT$ 1.07BNT$ 1.08BNT$ 1.12BNT$ 970.03MNT$ 1.25B
Cash Flow
Free Cash FlowNT$ 16.42MNT$ -175.78MNT$ 65.00KNT$ -28.73MNT$ 617.24M
Operating Cash FlowNT$ 20.93MNT$ -173.09MNT$ 7.46MNT$ -21.27MNT$ 629.07M
Investing Cash FlowNT$ 83.37MNT$ -110.87MNT$ 145.46MNT$ -84.95MNT$ -306.07M
Financing Cash FlowNT$ -34.64MNT$ -17.40MNT$ -19.99MNT$ -15.84MNT$ -18.85M

Currency in TWD

TaiGen Biopharmaceuticals Holdings Limited Earnings and Revenue History

-800M0800M1.6B-2000 %-1000 %0 %1000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

TaiGen Biopharmaceuticals Holdings Limited Liabilities to Assets

0600M1.2B1.8B0 %8 %16 %24 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

TaiGen Biopharmaceuticals Holdings Limited Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

TaiGen Biopharmaceuticals Holdings Limited Forecast EPS vs Actual EPS

-0.3-0.2-0.100.10.20.30.4Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >